Neuromyopathy caused by long term colchicine therapy

作者：Park Hyung Jun; Lee Hyung-Soo; Koo Heasoo; Han Soo Jeong; Choi Euno; Lee Chan Young; Lee Seung Ah; Choi Young-Chul; Park Kee Duk^*

来源：Neurology Asia, 2018, 23(2): 185-188.

• colchicine
• toxicity
• muscular disease
• polyneuropathies

Colchicine-induced neuromyopathy is an extremely rare complication, and can develop in the setting of acute overdose or chronic administration in therapeutic doses. A 72-year-old man presented with proximal muscle weakness and myalgia. He had angina pectoris and Behcet's disease, leading to the treatment of colchicine (1.2 mg daily for about 6 years), cyclosporine, methylprednisolone, simvastatin, and aspirin. A biceps brachii muscle biopsy was performed and electron microscopic examination revealed scattered autophagic vacuoles. He was initially treated with steroid pulse therapy. However, muscle weakness did not improve. After the discontinuation of colchicine, muscle power and myalgia improved steadily. There should be heightened awareness of colchicine-induced neuromyopathy because that clinical suspicion is the most important diagnostic clue, and termination of colchicine is the only treatment.

• 出版日期2018-6